AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MEDICLINIC INTERNATIONAL PLC

Declaration of Voting Results & Voting Rights Announcements Mar 4, 2016

4946_rns_2016-03-04_a9376349-8b2e-4c8f-9fe7-ad93a999d5e4.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0215R

Mediclinic International PLC

04 March 2016

Mediclinic International plc (the "Company")

(Incorporated in England and Wales)

Company Number: 08338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

4 March 2016

NOTIFICATION OF CHANGE IN AUDITOR

Further to the announcement of 22 February 2016 regarding the change in the Company's auditor, the Company hereby advises that KPMG LLP, the Company's previous auditors, ceased to hold office on 19 February 2016 and, as required in terms of section 519(3) of the UK Companies Act 2006, have deposited a statement with the Company of the circumstances connected with them ceasing to hold office as auditors of the Company.

In accordance with the requirements of section 520(2) of the UK Companies Act 2006, a copy of the statement received from KPMG LLP has today been sent to all shareholders together with an explanatory letter from the Company's Chief Executive Officer, Danie Meintjes.

In compliance with UKLA Listing Rule 9.6.1 the Company announces that the following documents have been submitted electronically to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM:

·       letter from KPMG LLP including a statement of circumstances connected with ceasing to hold office as auditors; and

·       Chief Executive Officer's explanatory letter.

The documents will also be available shortly on the Investor Relations section of the Company's website at www.mediclinic.com.   

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Limited

For further information, please contact:

Company Secretary

Victoria Dalby               +44 (0)207 954 9528

Capita Company Secretarial Services Limited

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCSSEFWDFMSEDD

Talk to a Data Expert

Have a question? We'll get back to you promptly.